|The human RBPome: from genes and proteins to human disease|
Y Neelamraju, S Hashemikhabir, SC Janga
Journal of proteomics 127, 61-70, 2015
|Mutational landscape of RNA-binding proteins in human cancers|
Y Neelamraju, A Gonzalez-Perez, P Bhat-Nakshatri, H Nakshatri, ...
RNA biology 15 (1), 115-129, 2018
|Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers|
Y Gökmen-Polar, IT Vladislav, Y Neelamraju, SC Janga, S Badve
Scientific reports 5 (1), 8765, 2015
|Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer|
Y Gökmen-Polar, Y Neelamraju, CP Goswami, X Gu, G Nallamothu, ...
Modern pathology 28 (5), 677-685, 2015
|Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways|
Y Gökmen‐Polar, Y Neelamraju, CP Goswami, Y Gu, X Gu, G Nallamothu, ...
EMBO reports 20 (2), e46078, 2019
|Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias|
TL Olson, HJ Cheon, JC Xing, KC Olson, U Paila, CE Hamele, ...
Blood, The Journal of the American Society of Hematology 138 (8), 662-673, 2021
|Database of RNA binding protein expression and disease dynamics (READ DB)|
S Hashemikhabir, Y Neelamraju, SC Janga
Database 2015, 2015
|Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks|
S Nishtala, Y Neelamraju, SC Janga
Scientific Reports 6 (1), 25711, 2016
|Uncovering RNA binding proteins associated with age and gender during liver maturation|
P Chaturvedi, Y Neelamraju, W Arif, A Kalsotra, SC Janga
Scientific reports 5 (1), 1-10, 2015
|Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia|
F Rapaport, Y Neelamraju, T Baslan, D Hassane, A Gruszczynska, ...
Leukemia 35 (9), 2688-2692, 2021
|Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia|
L Barreyro, AM Sampson, C Ishikawa, KM Hueneman, K Choi, MA Pujato, ...
Science translational medicine 14 (635), eabb7695, 2022
|Targeted detection and quantitation of histone modifications from 1,000 cells|
NA Abshiru, JW Sikora, JM Camarillo, JA Morris, PD Compton, T Lee, ...
PloS one 15 (10), e0240829, 2020
|Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999|
F Rapaport, K Seier, Y Neelamraju, D Hassane, T Baslan, DT Gildea, ...
Blood cancer journal 12 (9), 137, 2022